Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MiNK Therapeutics was selected as a therapeutic cell platform for an ARPA-H BoSS team aiming to enable room—temperature cell therapy storage; ARPA-H has committed up to $87M across the four-year program.Material DetailsContext by AI AnalystThis is an early-stage strategic validation aligning MiNK’s…
Clinical-stage agenT-797 iNKT platform selected as therapeutic cell platform for ARPA-H BoSS program aimed at taking living medicines from cryogenic storage toward room temperatureARPA-H has committed up to $87 million across the four-year BoSS program to reduce cold-chain dependence and expand acc…